These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6752032)

  • 21. Protective efficacy of hybridoma type-specific antibody against experimental infection with group-B Streptococcus.
    Shigeoka AO; Pincus SH; Rote NS; Hill HR
    J Infect Dis; 1984 Mar; 149(3):363-72. PubMed ID: 6371154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity and protective activity in animals of a type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
    Wessels MR; Paoletti LC; Pinel J; Kasper DL
    J Infect Dis; 1995 Apr; 171(4):879-84. PubMed ID: 7706814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternal group B streptococcal immunization: capsular polysaccharide (CPS)-based vaccines and their implications on prevention.
    Palmeiro JK; De Carvalho NS; Botelho AC; Fracalanzza SE; Madeira HM; Dalla-Costa LM
    Vaccine; 2011 May; 29(21):3729-30. PubMed ID: 21414381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimation of group B streptococcus type III polysaccharide-specific antibody concentrations in human sera is antigen dependent.
    Bhushan R; Anthony BF; Frasch CE
    Infect Immun; 1998 Dec; 66(12):5848-53. PubMed ID: 9826364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mouse protection test for group B Streptococcus type III.
    Baltimore RS; Kasper DL; Vecchitto J
    J Infect Dis; 1979 Jul; 140(1):81-8. PubMed ID: 88492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cervical secretions in pregnant women colonized rectally with group B streptococci have high levels of antibodies to serotype III polysaccharide capsular antigen and protein R.
    Hordnes K; Tynning T; Kvam AI; Bevanger L; Brown TA; Jonsson R; Haneberg B
    Scand J Immunol; 1998 Feb; 47(2):179-88. PubMed ID: 9496695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection from group B streptococcal infection in neonatal mice by maternal immunization with recombinant Sip protein.
    Martin D; Rioux S; Gagnon E; Boyer M; Hamel J; Charland N; Brodeur BR
    Infect Immun; 2002 Sep; 70(9):4897-901. PubMed ID: 12183534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection.
    Baker CJ; Kasper DL
    N Engl J Med; 1976 Apr; 294(14):753-6. PubMed ID: 768760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal Sera.
    Fabbrini M; Rigat F; Rinaudo CD; Passalaqua I; Khacheh S; Creti R; Baldassarri L; Carboni F; Anderloni G; Rosini R; Maione D; Grandi G; Telford JL; Margarit I
    Clin Infect Dis; 2016 Sep; 63(6):746-753. PubMed ID: 27402816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoprecipitation and opsonic cross-reaction between type-14 pneumococcus and group-B streptococcus type III.
    Fischer GW; Lowell GH; Crumrine MH; Wilson SR
    Lancet; 1979 Jan; 1(8107):75-7. PubMed ID: 84130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective efficacy against group B streptococcal infection in neonatal mice delivered from preimmunized pregnants.
    Itoh T; Yan XJ; Nakano H; Yoshioka M
    Microbiol Immunol; 1986; 30(4):297-305. PubMed ID: 3523166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional activity of maternal and cord antibodies elicited by an investigational group B Streptococcus trivalent glycoconjugate vaccine in pregnant women.
    Fabbrini M; Rigat F; Tuscano G; Chiarot E; Donders G; Devlieger R; Filippini S; Frigimelica E; Forte P; Wittke F; Halperin SA; Slobod K; Grandi G; Margarit I
    J Infect; 2018 May; 76(5):449-456. PubMed ID: 29374589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of IgM antibody to group B Streptococcus type III in human infants.
    Boyer KM; Klegerman ME; Gotoff SP
    J Infect Dis; 1992 Jun; 165(6):1049-55. PubMed ID: 1583322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14.
    Guttormsen HK; Baker CJ; Nahm MH; Paoletti LC; Zughaier SM; Edwards MS; Kasper DL
    Infect Immun; 2002 Apr; 70(4):1724-38. PubMed ID: 11895934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Group B streptococcal colonization and serotype-specific immunity in pregnant women at delivery.
    Campbell JR; Hillier SL; Krohn MA; Ferrieri P; Zaleznik DF; Baker CJ
    Obstet Gynecol; 2000 Oct; 96(4):498-503. PubMed ID: 11004347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution of B streptococcal type antigens among streptococci of serological groups B, G and L.
    Wibawan IW; Lämmler C
    Zentralbl Bakteriol; 1990 Sep; 273(4):471-7. PubMed ID: 2123387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection.
    Baker CJ; Edwards MS; Kasper DL
    Pediatrics; 1981 Oct; 68(4):544-9. PubMed ID: 7033911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An oligosaccharide-tetanus toxoid conjugate vaccine against type III group B Streptococcus.
    Paoletti LC; Kasper DL; Michon F; DiFabio J; Holme K; Jennings HJ; Wessels MR
    J Biol Chem; 1990 Oct; 265(30):18278-83. PubMed ID: 2120228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human antibody to the group-specific polysaccharide of group B Streptococcus.
    Anthony BF; Concepcion NF; Concepcion KF
    J Infect Dis; 1985 Feb; 151(2):221-6. PubMed ID: 3881538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunodeterminant specificity of human immunity to type III group B streptococcus.
    Kasper DL; Baker CJ; Baltimore RS; Crabb JH; Schiffman G; Jennings HJ
    J Exp Med; 1979 Feb; 149(2):327-39. PubMed ID: 84042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.